Article
Potency of an oxidation-resistant mutant of secretory leukocyte proteinase inhibitor in lipopolysaccharide-induced emphysema in hamsters.
Pulmonary pharmacology - 1 Mar 1993
Stolk J, Heinzel-Wieland R, Saunders D, Dijkman J H, Steffens G
Abstract excerpt
Secretory leukocyte inhibitor (SLPI) is a potent inhibitor of serine proteinases, but sensitive to oxidative inactivation due to a methionine residue in the active centre of the inhibitor. We compared the potency of an oxidation-resistant mutant of recombinant SLPI with native recombinant SLPI in lipopolysaccharide (LPS)-induced emphysema in the hamster. Application of this oxidation-resistant mutant reduced the...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
